Cancer risk prediction is a critical step towards the development of targeted cancer prevention and screening
policies. There is a growing awareness that cancer risk prediction studies may be distorted by detection bias,
particularly in screened populations. Detection bias occurs when screening and diagnostic patterns vary in
association with potential risk factors. Detection bias can exaggerate or attenuate estimated disease-risk factor
associations and may adversely affect our ability to develop sound prevention and screening policies.
The objective of this application is to change the way that detection bias is assessed and addressed in cancer
risk prediction. We will harness the technique of disease natural history modeling to decouple the underlying risk
of disease from observed screening and diagnosis histories. We will rigorously investigate the performance of
disease modeling to reduce detection bias and will apply our approach to assess and address detection bias
that may already be impacting early detection guidelines in prostate and breast cancer. We will disseminate our
models via an online user interface that will permit investigators conducting risk prediction studies in screened
populations to assess their studies' susceptibility to detection bias. Finally, we will study the impact of detection
bias on policy-relevant outcomes via a proof-of-concept study of prostate cancer screening.
Our specific aims are as follows: Aim 1 [Methods development]: Develop and validate a cancer modeling
method for assessing and reducing detection bias in risk prediction studies based on screened populations; Aim
2 [Breast density application]: Apply the method developed in Aim 1 to assess and remediate any detection
bias in published associations between breast density and breast cancer risk. Despite the major policy
implications of findings that breast density leads to an elevated risk of breast cancer diagnosis, these findings
have never been interrogated for detection bias; Aim3 [Software dissemination]: Develop, test, and deploy an
online user interface that will permit investigators conducting cancer risk prediction studies in screened
populations to assess the potential detection bias; Aim 4 [Policy impact]: Assess the impact of detection bias
on harm-benefit tradeoffs of candidate prostate cancer screening policies as a proof of concept for the translation
of detection bias to the policy setting.
This application will pioneer the use of disease modeling as tool for addressing a source of bias that may be
present across a wide range of policy-driving cancer risk predictions. The investigator team is comprised of
leading investigators in the development of disease models for early detection. The proposed work will produce
the most rigorous analysis to date of the way that detection bias works and how it may be addressed in practice.
If you are accessing this page during weekend or evening hours, the database may currently be offline for maintenance and should operational within a few hours. Otherwise, we have been notified of this error and will be addressing it immediately.
Please contact us
if this error persists.
We apologize for the inconvenience.
- The DCCPS Team.